Study of KK3910 in healthy people and those with high blood pressure
Part of Heart & circulation clinical trials.
This study tests a new medicine called KK3910, first in healthy volunteers to check safety, then in Japanese patients with essential hypertension (high blood pressure) to see if it helps lower blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be Japanese (for parts 1, 2, and 3) or a non-Asian healthy man (for part 1 only).
- Your age must be between 18 and 55 (or 65-80 for the elderly group in part 1), or 18-65 (part 2), or 18-80 (part 3).
- Your body mass index (BMI) must be within a specific range set by the study doctors.
- You cannot have a history of serious diseases like heart, lung, kidney, liver, or stomach problems, cancer, or mental health disorders.
- You cannot have a drug allergy, alcohol or drug addiction, or be a smoker during the study period.
- You cannot be pregnant, breastfeeding, or planning to have a child (for parts 2 and 3).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new blood pressure medication called HJB647 in Japanese adults with elevated or high blood pressure. The study aims to see if the drug is safe and how the body handles it.
This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.
This trial tests an experimental drug called IBI3016 for lowering high blood pressure. It is specifically for Japanese adults who have high blood pressure while currently on treatment.
This study tests a new medicine, MWX401, to see if it is safe and how it works in the body. It includes healthy adults and people with mild high blood pressure, with frequent check-ups to ensure safety.
This early-stage trial tests a new oral medication (HS-10522) to see if it is safe and how the body handles it. It includes both healthy people and those with mild high blood pressure, and may help lower blood pressure in the future.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
Hear when a new Healthy Volunteers Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.